Pathways and Standards

SPEN Pathways

Pathway 1: First Seizure

Pathway 2: Diagnosis and Initial Management of Epilepsy

Pathway 3:  Continuing Epileptic Seizures

Publication Date: July 2024

Revision Date: March 2025

These pathways are not intended to be construed or to serve as a standard of care. Standards of care are determined on the basis of all clinical data available for an individual case and are subject to change as scientific knowledge and technology advance and patterns of care evolve. Adherence to pathway recommendations will not ensure a successful outcome in every case, nor should they be construed as including all proper methods of care or excluding other acceptable methods of care aimed at the same results. The ultimate judgement must be made by the appropriate healthcare professional(s) responsible for clinical decisions regarding a particular clinical procedure or treatment plan. This judgement should only be arrived at following discussion of the options with the patient, covering the diagnostic and treatment choices available. It is advised, however, that significant departures from the national pathways or any local guidance derived from them should be fully documented in the patient’s case notes at the time the relevant decision is taken.

SIGN 159 National Clinical Guideline

SIGN 159 National Clinical Guideline

SPEN Joint Clinic Guidance

SPEN Joint Paediatric Epilepsy Clinic Guidance

SPEN Buccal Midazolam Guideline

SPEN Buccal Midazolam Guideline

SPEN New Normal Recommendations

SPEN New Normal Recommendations